20
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
TP1451 | TAT peptide | ||
TAT peptide corresponds to the polycationic aa49-57 region of TAT protein. TAT peptide is a cell-penetrating peptide (CPP) used to cargo larger molecules through the lipophilic barrier of the cellular membranes to delive... | |||
T83727 | Tat-NTS Peptide TFA | Tat-Nuclear Translocation Signal Peptide | |
Tat-NTS peptide, a cell-penetrating compound, comprises the HIV-1 Tat protein transduction domain fused with a 10-amino acid sequence (residues 228-237) from the repeat III domain of annexin A1, serving as a nuclear tran... | |||
TP1809 | TAT | HIV Protease | |
TAT peptide (YGRKKRRQRRR), originating from the human immunodeficiency virus-1 (HIV-1) transactivator of transcription (TAT), enhances the solubility and production of heterologous proteins[1]. This cell-penetrating pept... | |||
TP1585 | Sgp91 ds-tat Peptide 2, scrambled | ||
This peptide is a scrambled sequence of NADPH oxidase assembly peptide inhibitor gp91 ds-tat. It is used as a control peptide. It is two amino acid residues shorter at the N-terminus compared to the scrambled gp91 ds-tat... | |||
T75759 | TAT peptide TFA | ||
TAT peptide (TFA), a cell-penetrating peptide (GRKKRRQRRRPQ) originating from HIV-1's trans-activating transcriptional activator (Tat), facilitates intracellular delivery [1] [2]. | |||
T81034 | TAT-NSF700 Fusion Peptide | ||
TAT-NSF700 Fusion Peptide, a potent inhibitor of N-ethyl-maleimide-sensitive factor (NSF), possesses the ability to penetrate cell membranes and directly interact with intracellular organelles [1]. | |||
T76546 | TAT-HA2 Fusion Peptide | ||
TAT-HA2 Fusion Peptide, a peptide-based delivery agent, synergizes the pH-sensitive HA2 fusion peptide from Influenza with the cell-penetrating peptide TAT from HIV. This compound facilitates the cellular uptake of macro... | |||
T80246 | TAT-GluR23A Fusion Peptide | ||
TAT-GluR23A Fusion Peptide is a bioactive peptide comprising the GluR23A sequence—residues 869 to 877 of GluR23Y with alanine replacing tyrosine—and an 11 amino acid cell-permeable HIV Trans-Activator of Transcription (T... | |||
T81035 | TAT-NSF222 Fusion Peptide | ||
TAT-NSF222 Fusion Peptide is a bifunctional polypeptide comprising a TAT domain, facilitating cellular uptake via macropinocytosis, and an NSF domain, which acts as an inhibitor of N-ethylmaleimide-sensitive factor (NSF)... | |||
T78040 | Tat-peptide 190-208 TFA | ||
Tat-peptide 190-208 TFA is a Tat-labeled, cell-permeable fusion peptide derived from residues 190-208 of rat G3BP1. The HIV-derived Tat sequence, positioned at the peptide's least conserved region, confers cellular perme... | |||
T83670 | F1 TFA | Tat-IKIP (46-60),Tat-Inhibitor of NF-κB Kinase-interacting Peptide | |
F1, an anti-inflammatory peptide, incorporates the HIV-1 Tat protein transduction domain linked with a 15-amino acid sequence from residues 46-60 of the inhibitor of NF-κB kinase-interacting peptide (IKIP). It effectivel... | |||
T78041 | Tat-peptide control 168-189 TFA | ||
Tat-peptide 168-189, a cell-permeable, Tat-labeled fusion peptide derived from residues 168-189 of rat G3BP1, features the HIV Tat sequence at its least conserved terminus to enhance cellular uptake. It serves as the neg... | |||
TP2109L | AT 14 acetate | Nrf2 | |
TAT 14 acetate, a 14-mer peptide, is an Nrf2 activator with anti-inflammatory properties. TAT 14 acetate increases Nrf2 protein levels due to targeting the Nrf2 binding site on Keap1, but has no effect on Nrf2 mRNA expre... | |||
TP1185L | Cys-TAT(47-57) acetate(583836-55-9 Free base) | Cys-TAT(47-57) acetate(583836-55-9 Free base) | HIV Protease |
Cys-TAT(47-57) acetate is derived from the HIV-1 transactivating protein. Cys-TAT(47-57) acetate is an arginine rich peptide that can penetrate cells. | |||
T9632 | CDK9-IN-30 | HIV Protease | |
CDK9-IN-30 is one of the Tat peptide derivatives and inhibits HIV-1 long terminal repeat-activated transcription. | |||
T35924 | Tat-NR2Baa | Tat-NR2Baa | |
Tat-NR2BAA is an inactive control peptide of Tat-NR2B9c. It shares a similar sequence with Tat-NR2B9c, but possesses a double-point mutation in the COOH terminal tSXV motif. This mutation renders Tat-NR2BAA unable to bin... | |||
T41204 | TAT-Gap19(I130A) | TAT-Gap19(I130A) | |
TAT-Gap19(I130A) is a control peptide for TAT-Gap19, a Cx43 hemichannel blocker. TAT-Gap19(I130A) consists of TAT-GAP19 with a I130A amino acid residue change at a key residue for GAP19 activity. In C6 glioma cells expre... | |||
T76377 | Cdk2/Cyclin Inhibitory Peptide II | ||
Cdk2/Cyclin Inhibitory Peptide II (Tat-LDL), a CDK2 inhibitor, demonstrates dose-dependent cytotoxic effects on U2OS osteosarcoma cells [1]. | |||
T80514 | TAT-SAMβA | PKC | |
TAT-SAMβA, an RNAENFDRF (SAMβA) peptide conjugated to the TAT 47–57 protein-derived cell-penetrating peptide, acts as a selective antagonist of the Mfn1-βIIPKC association. It has been shown to protect mouse embryonic fi... | |||
TP1185 | Cys-TAT(47-57) | Cys-[HIV-Tat (47-57)] | |
Cys-TAT(47-57) (Cys-[HIV-Tat (47-57)]) is an arginine rich cell penetrating peptide derived from the HIV-1 transactivating protein.This peptide corresponds to the protein transduction domain of the TAT protein. |